New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
BioNexus Gene Lab Corp.
BGLC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

8M

Medical - Diagnostics & Research

Next Earning date - 18 Nov 2024

8M

Medical - Diagnostics & Research

Next Earning date - 18 Nov 2024

0.43USD
Shape0.00 ( 0.18%)
favorite-chart

Relative Strenght

85
favorite-chart

Volume Buzz

-87%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

87%

Quote Panel

Shape
Updated October 3, 2024
1W -2.22 % 1M 0.28 % 3M -6.49 % 1Y -42.54 %

Key Metrics

Shape
  • Market Cap

    7.79M


  • Shares Outstanding

    17.97M


  • Share in Float

    11.71M


  • Dividende

    0


  • Earning Date

    18 Nov 2024


  • Price Target

    0.4338


  • Average Volume

    397569


  • Beta

    1.84


  • Range

    0.31-3.39


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.bionexusgenelab.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.85x

P/S Ratio

0.80x

P/B Ratio

0.0

Debt/Equity

-24.0%

Net Margin

$-0.1

EPS

How BGLC compares to sector?

P/E Ratio

Relative Strength

Shape

BGLC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.01
vs 0

Q3.22

arrow
arrow

N/A

-0.01
vs 0.02

Q4.22

arrow
arrow

N/A

-0.01
vs 0.01

Q1.23

arrow
arrow

N/A

-0.00
vs 0

Q2.23

arrow
arrow

N/A

-0.16
vs -0.01

Q3.23

arrow
arrow

N/A

-0.02
vs -0.01

Q4.23

arrow
arrow

N/A

NA
vs -0.01

Q1.24

arrow
arrow

N/A

-0.02
vs -0.00

Q2.24

arrow
arrow

+106%

0.01
vs -0.16

Q3.24

arrow
arrow

+7787%

1.54
vs -0.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-20%

2.5M  vs 3.1M

Q3.22

arrow
arrow

-28%

2.6M  vs 3.6M

Q4.22

arrow
arrow

-12%

2.8M  vs 3.2M

Q1.23

arrow
arrow

-22%

2.4M  vs 3M

Q2.23

arrow
arrow

+3%

2.6M  vs 2.5M

Q3.23

arrow
arrow

-1%

2.6M  vs 2.6M

Q4.23

arrow
arrow

-20%

2.3M  vs 2.8M

Q1.24

arrow
arrow

+0%

2.4M  vs 2.4M

Q2.24

arrow
arrow

-23%

2M  vs 2.6M

Q3.24

arrow
arrow

-17%

2.1M  vs 2.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-1%

-0.01
vs -0.02

Q4.22

arrow
arrow

-2%

-0.02
vs -0.01

Q1.23

arrow
arrow

-1%

-0.01
vs -0.02

Q2.23

arrow
arrow

-4%

-0.04
vs -0.01

Q3.23

arrow
arrow

-27%

-0.27
vs -0.04

Q4.23

arrow
arrow

+3%

0.03
vs -0.27

Q1.24

arrow
arrow

-1%

-0.01
vs 0.03

Q2.24

arrow
arrow

+2%

0.02
vs -0.01

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News